A, C., WT, C., L, C., CT, H., & LN, C. (2023). Triple therapy for Helicobacter pylori eradication and the risk of hypoglycemia in patients with diabetes: A population-based cohort study. BMC public health, 23(1), 1772. https://doi.org/10.1186/s12889-023-16689-2
Chicago Style (17th ed.) CitationA, Chang, Chen WT, Chan L, Hong CT, and Chien LN. "Triple Therapy for Helicobacter Pylori Eradication and the Risk of Hypoglycemia in Patients with Diabetes: A Population-based Cohort Study." BMC Public Health 23, no. 1 (2023): 1772. https://doi.org/10.1186/s12889-023-16689-2.
MLA (9th ed.) CitationA, Chang, et al. "Triple Therapy for Helicobacter Pylori Eradication and the Risk of Hypoglycemia in Patients with Diabetes: A Population-based Cohort Study." BMC Public Health, vol. 23, no. 1, 2023, p. 1772, https://doi.org/10.1186/s12889-023-16689-2.